The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) closed the day trading at $6.18 down -2.37% from the previous closing price of $6.33. In other words, the price has decreased by -$2.37 from its previous closing price. On the day, 2.39 million shares were traded. BDRX stock price reached its highest trading level at $6.22 during the session, while it also had its lowest trading level at $5.0.
Ratios:
For a better understanding of BDRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.63 and its Current Ratio is at 3.63. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on February 08, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDRX now has a Market Capitalization of 3828652 and an Enterprise Value of 382861672448.
Stock Price History:
The Beta on a monthly basis for BDRX is 0.98, which has changed by -0.8875666 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, BDRX has reached a high of $92.00, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is -7.79%, while the 200-Day Moving Average is calculated to be -60.05%.
Shares Statistics:
Over the past 3-months, BDRX traded about 140.79K shares per day on average, while over the past 10 days, BDRX traded about 64400 shares per day. Shares short for BDRX as of 1760486400 were 27160 with a Short Ratio of 0.19, compared to 1757894400 on 13531. Therefore, it implies a Short% of Shares Outstanding of 27160 and a Short% of Float of 4.38.
Earnings Estimates
Analysts are recommending an EPS of between -$0.4 and -$0.4 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is -$0.1, with 1.0 analysts recommending between -$0.1 and -$0.1.
